Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05471947 · ClinicalTrials.gov registry record · Phase 4
TCA 15% Chemical Peel for Improvement in Hand Lentigines
A Phase 4 study, sponsored by Main Line Center for Laser Surgery.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT05471947: Completed Phase 4 study, sponsored by Main Line Center for Laser Surgery.
NCT05471947 is a Phase 4 study that has completed, run by Main Line Center for Laser Surgery. The registered enrollment target is 20 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05471947, a Phase 4 study, has completed, sponsored by Main Line Center for Laser Surgery.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy of the a 15% trichloroacetic acid + 3% glycolic acid peel combination for treatment of lentigines on the hands. This peel combination is sold over the counter. Patients will receive 3 treatments (spaced 4 weeks).
Primary Outcome
Photos will be graded on a 5 point scale (0=no change, 1=1-25% change, 2=26-50% change, 3=51-75% change, 4=76-100% change)
Interventions
- DRUG 15% Trichloroacetic acid + 3% glycolic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-03-15 |
| Est. Completion | 2024-12-01 |
| Phase | Phase 4 |
What the finished NCT05471947 record still lists
NCT05471947 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which 15% Trichloroacetic acid + 3% glycolic acid is the first listed.
NCT05471947 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05471947 about?
NCT05471947 is a clinical study titled "TCA 15% Chemical Peel for Improvement in Hand Lentigines". This study will evaluate the efficacy of the a 15% trichloroacetic acid + 3% glycolic acid peel combination for treatment of lentigines on the hands. This peel combination is sold over the counter. Patients will receive 3 treatments (spaced 4 weeks).
What is the current status of trial NCT05471947?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2023-03-15. Estimated completion is 2024-12-01.
What interventions are being tested in trial NCT05471947?
The interventions under investigation include: 15% Trichloroacetic acid + 3% glycolic acid (DRUG).
Who is sponsoring clinical trial NCT05471947?
This trial is sponsored by Main Line Center for Laser Surgery, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05471947's enrollment target sits among peer trials
20 1753rd of 2000 higher than 167 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI